A Multicenter, Relapse Prevention Study With Levomilnacipran Extended Release (ER) in Participants With Major Depressive Disorder
Condition(s):Depressive Disorder, MajorLast Updated:October 29, 2018Completed
Hide Studies Not Open or Pending
Condition(s):Depressive Disorder, MajorLast Updated:October 29, 2018Completed
Condition(s):FibromyalgiaLast Updated:November 20, 2009Completed
Condition(s):FibromyalgiaLast Updated:February 16, 2011Completed
Condition(s):FibromyalgiaLast Updated:January 20, 2010Completed
Condition(s):Fibromyalgia SyndromeLast Updated:July 11, 2013Completed
Condition(s):Major Depressive DisorderLast Updated:August 14, 2019Completed
Condition(s):None (i.e. Healthy Volunteers)Last Updated:October 6, 2021Unknown status
Condition(s):Major Depressive DisorderLast Updated:August 14, 2019Completed
Condition(s):FibromylagiaLast Updated:July 8, 2014Unknown status
Condition(s):FibromyalgiaLast Updated:December 24, 2007Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.